INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Other acquisition or dispositionVerified data

Mirsaeedi-Farahani Keyvan reported ADGM

Director · Adagio Medical Holdings, Inc. · Common Stock

Side
J
Value
—
Shares
12.8K
Price
—
Executed
Sep 27, 2024
Disclosed
Oct 13, 2026
Disclosure timeline746 days from execution to publication · legal deadline 2 business days
Sep 27 executedOct 13, 2026 disclosed

ADGM · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
27/ 100 · ROUTINE
Methodology →
  • Transaction type+3 / 20

    Other acquisition or disposition

  • Relative size+1 / 25

    No reported dollar value · new position

  • Filing timing+15 / 15

    Disclosed 532 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ADGM

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    24
    MP
    Moran Timothy P.Director
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    30.0K sh
    		Jun 16, 2026Aug 12, 2026
    traded Jun 16, 2026
    		+57dSEC FORM 4

    Evidence

    24
    MK
    Mirsaeedi-Farahani KeyvanDirector
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    30.0K sh
    		Jun 16, 2026Aug 12, 2026
    traded Jun 16, 2026
    		+57dSEC FORM 4

    Evidence

    24
    MO
    Mishan OrlyDirector
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    100.0K sh
    		Jun 16, 2026Aug 12, 2026
    traded Jun 16, 2026
    		+57dSEC FORM 4

    Evidence

    24
    SS
    Salmon SeanDirector
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    30.0K sh
    		Jun 16, 2026Aug 12, 2026
    traded Jun 16, 2026
    		+57dSEC FORM 4

    Evidence

    5
    KD
    Kaster DeborahChief Financial Officer
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    490.5K sh
    		Mar 6, 2026Mar 9, 2026
    traded Mar 6, 2026
    		+3dSEC FORM 4

    Evidence

    5
    UT
    Usen ToddDirector, Chief Executive Officer
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    800.0K sh
    		Mar 6, 2026Mar 9, 2026
    traded Mar 6, 2026
    		+3dSEC FORM 4

    Evidence

    46
    KD
    Kaster DeborahChief Financial Officer
    ADGMAdagio Medical Holdings, Inc.
    Open-market purchase
    		BUY$18K
    15.0K sh
    		Dec 16, 2025Dec 18, 2025
    traded Dec 16, 2025
    		+2dSEC FORM 4

    Evidence

    49
    UT
    Usen ToddDirector, Chief Executive Officer
    ADGMAdagio Medical Holdings, Inc.
    Open-market purchase
    		BUY$226K
    207.3K sh
    		Dec 12, 2025Dec 15, 2025
    traded Dec 12, 2025
    		+3dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002031256-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Sep 27, 2024
    Published
    Oct 13, 2026
    Ingested by INSIDER
    Nov 5, 02:12 UTC
    Last re-read
    Nov 5, 02:12 UTC

    Extracted facts

    Filer
    Mirsaeedi-Farahani Keyvan
    Role
    Director
    Transaction
    Other acquisition or dispositionAs filed: “J”
    Asset
    Adagio Medical Holdings, Inc.
    Ticker
    ADGM
    Shares
    12.8K
    Price per share
    $0
    Execution date (reported)
    Sep 27, 2024
    Owned after transaction
    12.8K shares
    Days from execution to publication
    746

    What this establishes

    Mirsaeedi-Farahani Keyvan filed this Form 4 reporting a other acquisition or disposition of ADGM on Sep 27, 2024. It became public on Oct 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Mirsaeedi-Farahani Keyvancik:0002031256
    Issuer
    Adagio Medical Holdings, Inc.cik:0002006986

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.